Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group"

Angiology. 2017 Aug;68(7):598-607. doi: 10.1177/0003319716676721. Epub 2016 Nov 12.


The incidence of ST-segment elevation myocardial infarction (STEMI) has significantly decreased. Conversely, the rate of non-STEMI (NSTEMI) has increased. Patients with NSTEMI have lower short-term mortality compared to patients with STEMI, whereas at long-term follow-up, the mortality becomes comparable. This might be due to the differences in baseline characteristics, including older age and a greater prevalence of comorbidities in the NSTEMI population. Although antithrombotic strategies used in patients with NSTEMI have been well studied in clinical trials and updated guidelines are available, patterns of use and outcomes in clinical practice are less well described. Thus, a panel of Italian cardiology experts assembled under the auspices of the "Campania NSTEMI Study Group" for comprehensive discussion and consensus development to provide practical recommendations, for both clinical and interventional cardiologists, regarding optimal management of antithrombotic therapy in patients with NSTEMI. This position article presents and discusses various clinical scenarios in patients with NSTEMI or unstable angina, including special subsets (eg, patients aged ≥85 years, patients with chronic renal disease or previous cerebrovascular events, and patients requiring triple therapy or long-term antithrombotic therapy), with the panel recommendations being provided for each scenario.

Keywords: NSTEMI; PCI; acute myocardial infarction; antiplatelets; antithrombotic.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Consensus
  • Female
  • Follow-Up Studies
  • Hospital Mortality
  • Humans
  • Male
  • Myocardial Infarction / drug therapy*
  • Non-ST Elevated Myocardial Infarction / drug therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Registries
  • ST Elevation Myocardial Infarction / drug therapy
  • Treatment Outcome*


  • Platelet Aggregation Inhibitors